Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
39,570,451
-
Share change
-
-7,637,022
-
Total reported value
-
$86,350,850
-
Put/Call ratio
-
274%
-
Price per share
-
$2.18
-
Number of holders
-
63
-
Value change
-
-$22,510,362
-
Number of buys
-
32
-
Number of sells
-
30
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q3 2021
As of 30 Sep 2021,
Aptose Biosciences Inc. - Common Shares was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,570,451 shares.
The largest 10 holders included
DRW Securities, LLC, Nantahala Capital Management, LLC, First Light Asset Management, LLC, 683 Capital Management, LLC, Cormorant Asset Management, LP, ORBIMED ADVISORS LLC, MORGAN STANLEY, SANDERS MORRIS HARRIS LLC, GOLDMAN SACHS GROUP INC, and P.A.W. CAPITAL CORP.
This page lists
63
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.